Foresight LabsA jacket, two journeys

Global

IARC To Review Carcinogenic Risks Of Key Industrial Chemicals In 2026

IARC will evaluate Tris(chloropropyl)phosphate, Butyraldehyde, and Cumyl Hydroperoxide for potential carcinogenic risks in March 2026. Industries using these chemicals should prepare for possible regulatory changes. Calls for experts, data, and observer status are open.

Published in April 2025. Dates, deadlines and stages may have changed since.

Dr Steven Brennan

3 min readAI-drafted, expert reviewed

IARC logo

The International Agency for Research on Cancer (IARC) will evaluate the carcinogenic hazards of three widely used industrial chemicals—Tris(chloropropyl)phosphate, Butyraldehyde, and Cumyl Hydroperoxide—during its Monographs Volume 141 meeting in March 2026. This assessment could lead to significant regulatory and compliance changes, impacting manufacturers, suppliers, and downstream industries.

Regulatory Implications For Chemical Manufacturers

The review, taking place in Lyon, France, from 3–10 March 2026, aims to determine whether these substances pose a carcinogenic risk to humans. This decision could lead to regulatory restrictions, labelling changes, or outright bans, depending on the findings. Tris(chloropropyl)phosphate (TCPP) is widely used in flame retardants, Butyraldehyde in chemical synthesis, and Cumyl Hydroperoxide in polymer production. The potential regulatory fallout could affect industries ranging from plastics and coatings to textiles and automotive manufacturing.

Health Concerns And Industry Response

The IARC Monographs programme reviews substances based on epidemiological data, cancer bioassays, and mechanistic studies. TCPP, for example, has been scrutinised for its role in flame retardants used in furniture, insulation, and electronics, where worker exposure and environmental persistence are concerns. Butyraldehyde, a volatile organic compound (VOC), is commonly used in resins, solvents, and adhesives, while Cumyl Hydroperoxide plays a key role in polymerisation and oxidation processes.

Industries reliant on these substances should review safety protocols and monitor potential regulatory developments, as reclassification could lead to changes in occupational exposure limits (OELs), product formulation requirements, or substitution mandates.

Key Deadlines For Stakeholders

To ensure transparency and scientific rigour, IARC has issued:

A Call for Experts (closes 2 June 2025): Scientists can apply to join the Working Group evaluating the substances.A Call for Data (closes 2 February 2026): Companies, research institutions, and industry bodies are encouraged to submit relevant studies.Request for Observer Status (closes 3 November 2025): Interested parties may apply to attend but cannot influence discussions.

What This Means For The Industry

If IARC classifies these chemicals as carcinogenic or probably carcinogenic, it could trigger regulatory reviews in the EU, UK, and other jurisdictions, affecting REACH compliance, product labelling, and workplace safety standards. Manufacturers should begin contingency planning, including risk assessments, alternative formulations, and supply chain adjustments to mitigate potential disruptions.

Questions about this change

What are the potential consequences of IARC classifying these chemicals as carcinogenic?

If IARC classifies these substances as carcinogenic, it could lead to stricter regulations, product reformulations, and workplace safety requirements. Companies may face new labelling laws, phase-out mandates, or stricter exposure limits, requiring proactive risk management and alternative solutions.

How can manufacturers prepare for the IARC review outcome?

Manufacturers should monitor regulatory developments, participate in the Call for Data, and assess potential substitutes for these chemicals. Engaging with trade associations and regulatory bodies can help companies stay ahead of potential compliance changes and supply chain disruptions.

Dr Steven Brennan

CEO and co-founder of Foresight, and a co-opted member of ECHA's Committee for Socio-economic Analysis. He holds a PhD in chemical engineering.

More from Dr Steven Brennan

Find out what this means for your products

Foresight follows changes like this one and shows where they reach your substances, products and markets.

Join 3,500+ professionals staying ahead

Foresight Weekly brings the week's regulatory changes across chemicals, product safety, sustainability, ESG and EHS into one email.

Free. Unsubscribe at any time.

Read by professionals at

  • Boeing
  • AstraZeneca
  • Siemens
  • PepsiCo
  • SpaceX